Retrospective analysis of monkeypox infection

Emerging Infectious Diseases

Volumn 14, Issue 4, 2008, Pages 592-599

  Dubois, Melissa E ^a   Slifka, Mark K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HUMAN; MONKEYPOX; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VACCINATION; VACCINIA; WESTERN BLOTTING;

EID: 42049106414     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1404.071044     Document Type: Article

References (29)

1. Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005;41:1765-71.
2. Rimoin AW, Kisalu N, Kebela-Ilunga B, Mukaba T, Wright LL, Formenty P, et al. Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerg Infect Dis. 2007;13:934-7.
3. Jezek Z, Fenner F, editors. Human monkeypox. Basel: Karger; 1988.
4. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342-50.
5. Sejvar JJ, Chowdary Y, Schomogyi M, Stevens J, Patel J, Karem K, et al. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis. 2004;190:1833-40.
6. Hammarlund E, Lewis MW, Carter SV, Amanna I, Hansen SG, Strelow LI, et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005;11:1005-11.
7. Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41:1742-51.
8. Lewis MW, Graham MB, Hammarlund E, Hanifin J, Slifka MK. Monkeypox without exanthem. N Engl J Med. 2007;356:2112-4.
9. Jezek Z, Marennikova SS, Mutumbo M, Nakano JH, Paluku KM, Szczeniowski M. Human monkeypox: a study of 2,510 contacts of 214 patients. J Infect Dis. 1986;154:551-5.
10. Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S, et al. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol. 2007;14:1318-27.
11. Seward JF, Galil K, Damon I, Norton SA, Rotz L, Schmid S, et al. Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002-2004. Clin Infect Dis. 2004;39:1477-83.
12. Klein KR, Atas JG, Collins J. Testing emergency medical personnel response to patients with suspected infectious disease. Prehospital Disaster Med. 2004;19:256-65.
13. Jezek Z, Nakano JH, Arita I, Mutombo M, Szczeniowski M, Dunn C. Serological survey for human monkeypox infections in a selected population in Zaire. J Trop Med Hyg. 1987;90:31-8.
14. Baxby D. The surface antigens of orthopoxviruses detected by cross-neutralization tests on cross-absorbed antisera. J Gen Virol. 1982;58:251-62.
15. Hutchinson HD, Ziegler DW, Wells DE, Nakano JH. Differentiation of variola, monkeypox, and vaccinia antisera by radioimmunoassay. Bull World Health Organ. 1977;55:613-23.
16. Lefkowitz EJ, Upton C, Changayil SS, Buck C, Traktman P, Buller RM. Poxvirus Bioinformatics Resource Center: a comprehensive poxviridae informational and analytical resource. Nucleic Acids Res. 2005;33:D311-6.
17. Gispen R, Brand-Saathof B. Three specific antigens produced in vaccinia, variola, and monkeypox infections. J Infect Dis. 1974;129:289-95.
18. Arita M, Tagaya I. Virion polypeptides of poxviruses. Arch Virol. 1980;63:209-25.
19. Turner A, Baxby D. Structural polypeptides of orthopoxvirus: their distribution in various members and location within the virion. J Gen Virol. 1979;45:537-45.
20. Harper L, Bedson HS, Buchan A. Identification of orthopoxviruses by polyacrylamide gel electrophoresis of intracellular polypeptides. I. Four major groupings. Virology. 1979;93:435-44.
21. Esposito JJ, Obijeski JF, Nakano JH. The virion and soluble antigen proteins of variola, monkeypox, and vaccinia viruses. J Med Virol. 1977;1:95-110.
22. Esposito JJ, Obijeski JF, Nakano JH. Serological relatedness of monkeypox, variola, and vaccinia viruses. J Med Virol. 1977;1:35-47.
23. Gispen R. Analysis of pox-virus antigens by means of double diffusion: a method for direct serological differentiation of cowpox. J Immunol. 1955;74:134-41.
24. Gispen R, Huisman J, Brand-Saathof B, Hekker AC. Immunofluorescence test for persistent poxvirus antibodies. Arch Gesamte Virusforsch. 1974;44:391-5.
25. Gispen R, Brand-Saathof BB, Hekker AC. Monkeypox-specific antibodies in human and simian sera from the Ivory Coast and Nigeria. Bull World Health Organ. 1976;53:355-60.
26. Demkowicz WE, Maa JS, Esteban M. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol. 1992;66:386-98.
27. Jones-Trower A, Garcia A, Meseda CA, He Y, Weiss C, Kumar A, et al. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin. Virology. 2005;343:128-40.
28. Marennikova SS, Malceva NN, Habahpaseva NA. ELISA - a simple test for detecting and differentiating antibodies to closely related orthopoxviruses. Bull World Health Organ. 1981;59:365-9.
29. Karem KL, Reynolds M, Braden Z, Lou G, Bernard N, Patton J, et al. Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol. 2005;12:867-72.